Pulmonary Arterial Pressure Above 30 mmHg Linked to Increased...
Jul 8, 2019 · Read about an Australian study suggesting that a pulmonary arterial pressure greater than 30 mmHg is associated with increased mortality.
Winrevair 'overwhelming' at treating advanced PAH in Phase 3 trial
Nov 27, 2024 · Winrevair (sotatercept-csrk) significantly reduced the risk of all-cause death, a lung transplant, or hospitalization among adults with pulmonary arterial hypertension (PAH) at …
Funding to advance novel PAH treatment from Australian scientists
Oct 23, 2024 · New funding from Biocurate will support a Monash University project that's developing a novel disease-modifying treatment for PAH.
FDA approves sotatercept, now Winrevair, to treat PAH in adults
Mar 27, 2024 · The FDA approved under-the-skin injection therapy sotatercept, now Winrevair, for adults in the U.S. with pulmonary arterial hypertension.
Including Uptravi early in PAH treatment lowers hospitalization risk
Nov 8, 2024 · Adding Uptravi (selexipag) to standard-of-care PAH treatment within six months may reduce the risk of hospitalization, per a study.
Adverse long-term outcomes in PAH are associated with high …
Dec 6, 2024 · The connection between PAH and blood sugar may be conveyed through pulmonary vascular remodeling, showing SHR as an indicator of risk.
Pulmonary Venous Hypertension (PVH) - Pulmonary Hypertension …
Jun 29, 2021 · Looking for information about pulmonary venous hypertension? PVH's causes, symptoms, diagnosis, and treatments are highlighted here.
Pulmonary Hypertension News – Pulmonary Hypertension News
Jan 13, 2025 · Stopping antidepressants during pregnancy tied to lower PPHN risk Discontinuing antidepressants during pregnancy might reduce the risk of persistent pulmonary hypertension …
Study links stopping Tyvaso to risk of disease worsening
Sep 11, 2024 · Tyvaso is well tolerated by PH patients with different types, and stopping raises by five times the risk of disease worsening, per a study.
Approval of new treatments for pulmonary hypertension prompts...
Apr 3, 2024 · After the FDA's approval of two new treatments for pulmonary hypertension, columnist Jen Cueva wonders if the drugs will be accessible to all.